Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page reorganizes the Locations section: a general 'Locations' heading is added with state-level entries (California, Florida, Georgia, Kentucky, Maryland, Michigan, Minnesota, Montana, Ohio) and Rozzano. The previous per-state 'Locations' headings are removed, and the Revision tag updates from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check53 days agoChange DetectedThe government funding status notice on the Study Details page for NCT03684694 has been removed; core trial information remains unchanged.SummaryDifference0.3%

- Check67 days agoChange DetectedResults data are now visible on the Study Details page, with the Results First Posted date listed as 2024-02-06, alongside outcome measures. This marks a shift from purely protocol content to published study results.SummaryDifference0.3%

- Check95 days agoChange DetectedUpdated to v3.2.0 with a new clinical term added and a government-operating-status notice; older version note v3.1.0 removed.SummaryDifference2%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.